Literature DB >> 3460685

Bilateral metachronous periosteal osteosarcoma.

A J Howat, D R Dickens, D W Boldt, K D Waters, P E Campbell.   

Abstract

The first case of bilateral metachronous periosteal osteosarcoma (OS) is reported. A 14-year-old white boy presented with a 1-month history of pain and swelling in his right thigh. Periosteal OS was diagnosed on a basis of the radiologic and pathologic findings. Treatment was with local resection and total hip replacement after a short course of high-dose methotrexate; multi-agent chemotherapy was continued postoperatively for 3 months. He remained well for 3 years. He then represented with a mass in the left femur that had been slowly growing for about 1 year. Radiologic and biopsy studies showed periosteal OS. Full investigations showed no evidence of metastatic disease. Treatment consisted of local resection without chemotherapy. He remained well for 6 months after the second excision until developing multiple pulmonary metastases. All further therapy was refused. The question as to whether the second tumor was a new primary lesion or a metastasis is discussed, together with possible differential diagnoses.

Entities:  

Mesh:

Year:  1986        PMID: 3460685     DOI: 10.1002/1097-0142(19860901)58:5<1139::aid-cncr2820580527>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  Periosteal osteosarcoma: a review of clinical evidence.

Authors:  Xin-Wei Liu; Ying Zi; Liang-Bi Xiang; Tian-Yu Han
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Bilateral synchronous tibial periosteal osteosarcoma with familial incidence.

Authors:  Aditya V Maheshwari; James S Jelinek; Nita L Seibel; Aurelia M Meloni-Ehrig; Dhruv Kumar; Robert M Henshaw
Journal:  Skeletal Radiol       Date:  2012-02-17       Impact factor: 2.199

3.  Case report 852. Periosteal osteosarcoma of femur.

Authors:  E R Melhem; R H Hruban; E K Fishman
Journal:  Skeletal Radiol       Date:  1994-07       Impact factor: 2.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.